Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2010 Sep 15;202(6):908–915. doi: 10.1086/655782

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2010 by the Infectious Diseases Society of America. All rights reserved.

PMC Copyright notice

Figure 1. — Effect of rs2234358 in the Genomics of Resistance to Immunodeficiency Virus (GRIV), Amsterdam Cohort Study (ACS), Multicenter AIDS Cohort Study (MACS), and USA HIV-1 study groups. A, Allelic frequency of rs2234358-T in the GRIV long-term nonprogressor (LTNP) population (n = 186) and the control group (CTR) (n = 697). Frequencies are also given for the 31 ACS subjects with LTNP (ACS LTNPs), for the remaining 285 ACS participants (ACS^*), for the 59 MACS subjects with LTNP (MACS LTNPs), and for the remaining 97 MACS participants (MACS^*). B, Kaplan-Meier survival curve derived from the ACS cohort for the time to AIDS-related death. Genotypes GG (green) (n = 76), GT (blue) (n = 171), and TT (black) (n = 69). C, Kaplan-Meier survival curve derived from the MACS cohort for time to clinical AIDS. Genotypes GG (green) (n = 45), GT (blue) (n = 72), and TT (black) (n = 39). D, Kaplan-Meier survival curve derived from the USA HIV-1 cohort for time to AIDS-related death. Genotypes GG (green) (n = 140), GT (blue) (n = 297), and TT (black) (n = 119).